Contact Dermatitis, Allergic: Multimedia

References

1. Jacobs JJ, Lehe CL, Hasegawa H, Elliott GR, Das PK. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol. Jun 2006;15(6):432-40. [Medline].

2. Novak N, Baurecht H, Schafer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol. Jun 2008;128(6):1430-5. [Medline].

3. Green CM, Holden CR, Gawkrodger DJ. Contact allergy to topical medicaments becomes more common with advancing age: an age-stratified study. Contact Dermatitis. Apr 2007;56(4):229-31. [Medline].

4. Assier-Bonnet H, Revuz J. [Topical neomycin: risks and benefits. Plea for withdrawal]. Ann Dermatol Venereol. 1997;124(10):721-5. [Medline].

5. Gonul M, Gul U. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids. Contact Dermatitis. Aug 2005;53(2):67-70. [Medline].

6. Cohen LM, Cohen JL. Erythema multiforme associated with contact dermatitis to poison ivy: three cases and a review of the literature. Cutis. Sep 1998;62(3):139-42. [Medline].

7. Lu LK, Warshaw EM, Dunnick CA. Prevention of nickel allergy: the case for regulation?. Dermatol Clin. Apr 2009;27(2):155-61, vi-vii. [Medline].

8. Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, Eichenfield LF. p-Phenylenediamine in black henna tattoos: a practice in need of policy in children. Arch Pediatr Adolesc Med. Aug 2008;162(8):790-2. [Medline].

9. Thyssen JP, White JM. Epidemiological data on consumer allergy to p-phenylenediamine. Contact Dermatitis. Dec 2008;59(6):327-43. [Medline].

10. Guin JD, Phillips D. Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis. Jun 1989;43(6):564-7. [Medline].

11. Larkin A, Rietschel RL. The utility of patch tests using larger screening series of allergens. Am J Contact Dermat. Sep 1998;9(3):142-5. [Medline].

12. Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):911-8. [Medline].

13. Rajagopalan R, Anderson RT, Sarma S, et al. An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis. Am J Contact Dermat. Sep 1998;9(3):149-54. [Medline].

14. [Guideline] Bernstein IL, Li JT, Bernstein DI, Hamilton R, et al. Allergy diagnostic testing: an updated practice parameter. Part 1. Ann Allergy Asthma Immunol. Mar 2008;100(3 Suppl 3):S15-S66.

15. [Guideline] Bernstein IL, Li JT, Bernstein DI, Hamilton R, et al. Allergy diagnostic testing: an updated practice parameter. Part 2. Allergy Asthma Immunol. Mar 2008;100(3 Suppl 3):S66-S121.

16. Taylor JS, Praditsuwan P, Handel D, Kuffner G. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience. Arch Dermatol. May 1996;132(5):515-8. [Medline].

17. Katsarou A, Armenaka M, Vosynioti V, Lagogianni E, Kalogeromitros D, Katsambas A. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol. Apr 2009;23(4):382-7. [Medline].

18. Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. Jan-Feb 2006;72(1):24-7. [Medline].

19. Shaffer MP, Belsito DV. Allergic contact dermatitis from glutaraldehyde in health-care workers. Contact Dermatitis. Sep 2000;43(3):150-6. [Medline].

20. Cohen DE, Brancaccio R, Andersen D, Belsito DV. Utility of a standard allergen series alone in the evaluation of allergic contact dermatitis: a retrospective study of 732 patients. J Am Acad Dermatol. Jun 1997;36(6 Pt 1):914-8. [Medline].

21. Diepgen TL, Coenraads PJ. The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health. Nov 1999;72(8):496-506. [Medline].

22. Hogan DJ. The prognosis of occupational contact dermatitis. Occup Med. Jan-Mar 1994;9(1):53-8. [Medline].

23. Hougeir FG, Yiannias JA, Hinni ML, Hentz JG, el-Azhary RA. Oral metal contact allergy: a pilot study on the cause of oral squamous cell carcinoma. Int J Dermatol. Mar 2006;45(3):265-71. [Medline].

24. Katagiri K, Arakawa S, Hatano Y, Fujiwara S. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. J Dermatol. Feb 2006;33(2):75-9. [Medline].

25. Kist JM, el-Azhary RA, Hentz JG, Yiannias JA. The contact allergen replacement database and treatment of allergic contact dermatitis. Arch Dermatol. Dec 2004;140(12):1448-50. [Medline].

26. Kligman AM. The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol. Nov 1966;47(5):393-409. [Medline].

27. Lawley TJ, Kubota Y. Cell adhesion molecules and cutaneous inflammation. Semin Dermatol. Sep 1991;10(3):256-9. [Medline].

28. Rietschel RL, Fowler JR Jr. Fisher's Contact Dermatitis. 5^th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001.

29. Shah M, Lewis FM, Gawkrodger DJ. Nickel as an occupational allergen. A survey of 368 nickel-sensitive subjects. Arch Dermatol. Oct 1998;134(10):1231-6. [Medline].

30. Shai A, Halevy S. Direct triggers for ulceration in patients with venous insufficiency. Int J Dermatol. Dec 2005;44(12):1006-9. [Medline].

31. Tadd C, Feldman S, Thompson S. Only 33% of Visits for Skin Disease in the US in 1995 Were to Dermatologists: Is Decreasing the Number of Dermatologists the Appropriate Response?. Dermatology Online [serial online]. 1998;4:Available at http://dermatology.cdlib.org/DOJvol4num1/original/thompson.html.

32. Templet JT, Hall S, Belsito DV. Etiology of hand dermatitis among patients referred for patch testing. Dermatitis. Mar 2004;15(1):25-32. [Medline].

33. Thompson T, Belsito DV. Allergic contact dermatitis from a diisocyanate in wool processing. Contact Dermatitis. Nov 1997;37(5):239. [Medline].

Further Reading

Keywords

contact dermatitis, allergic contact dermatitis, ACD, allergic dermatitis, skin allergy, contact hypersensitivity

Contributor Information and Disclosures

Author

Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, and Canadian Dermatology Association
Disclosure: Nothing to disclose.

Medical Editor

Donald Belsito, MD, Clinical Professor, Department of Internal Medicine, Division of Dermatology, University of Missouri at Kansas City; Private Practice, American Dermatology Associates, LLC
Donald Belsito, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, Dermatology Foundation, Kansas Medical Society, Noah Worcester Dermatological Society, Phi Beta Kappa, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting; Genetech Honoraria Consulting; Celgene Honoraria Consulting

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.